Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.

Saved in:
Bibliographic Details
Title: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
Authors: Kengo Shimazu1,2,3, Yuji Tada1, Takao Morinaga2, Masato Shingyoji4, Ikuo Sekine5, Hideaki Shimada6, Kenzo Hiroshima7, Takao Namiki3, Koichiro Tatsumi1, Masatoshi Tagawa2,8 mtagawa@chiba-cc.jp, Shimazu, Kengo9,10,11 (AUTHOR), Tada, Yuji9 (AUTHOR), Morinaga, Takao10 (AUTHOR), Shingyoji, Masato12 (AUTHOR), Sekine, Ikuo13 (AUTHOR), Shimada, Hideaki14 (AUTHOR), Hiroshima, Kenzo15 (AUTHOR), Namiki, Takao11 (AUTHOR), Tatsumi, Koichiro9 (AUTHOR), Tagawa, Masatoshi10,16 (AUTHOR)
Source: BMC Cancer. 5/2/2017, Vol. 17, p1-14. 14p. 1 Black and White Photograph, 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:14712407
DOI:10.1186/s12885-017-3300-y